EMRISE CORPORATION BUYS BACK COMMON STOCK WARRANTS FROM PRIMARY LENDEREliminates Possible Dilutive Impact of Warrants and Potential for Quarterly Non-Cash, Mark-to-Market AdjustmentsDURHAM, NC - September 28, 2010 - EMRISE CORPORATION (NYSE Arca: ERI), a multi-national manufacturer of defense, aerospace and industrial electronic devices and communications equipment, today announced that on August 30, 2010, it repurchased from its primary lender, for a total purchase price of $100,000, two warrants that would have entitled the lender to purchase an aggregate total of 775,758 shares of EMRISE common stock (each warrant represented the right to purchase 387,879 shares at exercise prices of $1.80 and $1.99, respectively). The warrants also had a cashless conversion provision, which, if utilized, would have resulted in no cash to the Company at the time the warrants were exercised. The warrants were originally issued to the primary lender by the Company on November 30, 2007, and amended and restated on February 12, 2009. By completing the repurchase of the warrants at the time EMRISE closed the sale of Advanced Control Components, Inc., (ACC), and paid down its debt, the Company was not subject to the anti-dilution provisions of the warrants, which would have required the Company to increase the number of shares of common stock underlying the warrants to an aggregate total of 1,363,972 shares and change the exercise price to $1.07778 per share. The anti-dilution provisions would have been triggered as a result of issuing to Charles Brand, the president and former principal shareholder of ACC, $450,000 worth of EMRISE common stock at a price per share of $1.07778, or 417,525 shares, as partial payment of the deferred payment obligations he is owed. "I believe the dilution caused by the warrants, particularly because of the anti-dilution provisions, would have negatively impacted the holdings of our current stockholders, and caused a measurable decrease in the price of our stock," Oliva added, noting that the shares would have represented a 5.5 percent dilution of the stock. "In addition, as long as those warrant agreements were in place, we were subject to recording a non-cash, mark-to-market adjustment each quarter due to any increase or decrease in the price of our stock. This non-cash, mark-to-market adjustment fluctuated substantially and was unpredictable. For example, assuming the volatility and discount rates remained consistent with those used June 30, 2010, if our stock price went up 20 percent, it would have negatively impacted profitability by approximately $130,000 and if our stock priced declined 20 percent, our profitability would have been increased by approximately $130,000. I believe the benefits of the potential positive impact on stockholder value of buying back the warrants, which removes the uncertainty of their dilutive effect and eliminates the potential for quarterly non-cash, mark-to-market adjustments, greatly exceed the price we paid to repurchase the warrants." The Company filed a Current Report on Form 8-K with the Securities and Exchange Commission on September 7, 2010, which included the details of the transaction. About EMRISE Corporation Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
|

